This powerful antioxidant may help inhibit melanin production, leading to a more even and radiant complexion
What is Rybelsus used for beyond diabetes
Since its initial approval, the Food and Drug Administration (FDA) has approved two additional indications: to reduce the risk of adverse cardiovascular events in adults with Type 2 diabetes and heart disease and to reduce worsening of kidney disease in adults with Type 2 diabetes and chronic kidney disease
However, high discontinuation rates, driven primarily by gastrointestinal adverse events, posed a significant barrier to achieving these outcomes
Tirzepatide (Mounjaro, Zepbound), a GLP-1/GIP dual agonist, produces greater weight loss and glucose reduction than GLP-1 agonists alone, validating the multi-agonist concept